Catalyst Funds Management Pty »

Cytomx Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $243k 52k 4.70

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
Bank of America Corporation
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Point72 Asset Management
Citadel Advisors
State Street Corporation
BlackRock
Baker Bros. Advisors
Elmind Capital
Nextech Invest
Marshall Wace
Millennium Management

View all funds holding Cytomx Therapeutics